155 related articles for article (PubMed ID: 8667055)
1. Radioimmunoscintigraphy in patients with early stage cutaneous malignant melanoma.
Blend MJ; Hyun H; Patel B; Sullivan K; Salk D
J Nucl Med; 1996 Feb; 37(2):252-7. PubMed ID: 8667055
[TBL] [Abstract][Full Text] [Related]
2. Role of technetium 99m-labeled monoclonal antibody in the management of melanoma patients.
Blend MJ; Ronan SG; Salk DJ; Gupta TK
J Clin Oncol; 1992 Aug; 10(8):1330-7. PubMed ID: 1634923
[TBL] [Abstract][Full Text] [Related]
3. Two phase scintigraphic mapping of lymphatic drainage in cutaneous melanoma using 99mTc-sulfur microcolloid/99mTc antimelanoma antibody.
Limouris GS; Voliotopoulos V; Kondi-Paphiti A; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1667-9. PubMed ID: 9179215
[TBL] [Abstract][Full Text] [Related]
4. Role of radioimmunoscintigraphy and SPET in the diagnosis of patients with malignant melanoma.
Sergieva S; Goranov K; Piperkova E; Tzingilev D; Trojanova P; Peitcheva E; Kulkin V
Nucl Med Commun; 1994 Mar; 15(3):168-72. PubMed ID: 8190407
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoscintigraphy with 99mTc-225.28S-F(ab')2 in cutaneous and ocular melanomas: cases of particular clinical interest.
Salzillo F; Mele M; Lombardo T; Delle Noci N; Minervini C; D'Addabbo A
J Nucl Biol Med (1991); 1993 Dec; 37(4):191-7. PubMed ID: 8172959
[TBL] [Abstract][Full Text] [Related]
6. Improved staging of B-cell non-Hodgkin's lymphoma patients with 99mTc-labeled LL2 monoclonal antibody fragment.
Blend MJ; Hyun H; Kozloff M; Levi H; Mills GQ; Gasparini M; Buraggi G; Hughes L; Pinsky CM; Goldenberg DM
Cancer Res; 1995 Dec; 55(23 Suppl):5764s-5770s. PubMed ID: 7493343
[TBL] [Abstract][Full Text] [Related]
7. Detection of recurrent malignant melanoma with 99mTc-MIBI scintigraphy.
Alonso O; Martinez M; Mut F; Delgado L; Lago G; De Boni D; Bazzano C; Núñez M; Garcés M; Muse IM; Roca R; Touya E; Espasandín J; Priario J
Melanoma Res; 1998 Aug; 8(4):355-60. PubMed ID: 9764811
[TBL] [Abstract][Full Text] [Related]
8. Anti-melanoma monoclonal antibody 225.28S immunoscintigraphy in metastatic melanoma.
Böni R; Huch Böni RA; Steinert H; Dummer R; Burg G; von Schulthess GK
Dermatology; 1995; 191(2):119-23. PubMed ID: 8520057
[TBL] [Abstract][Full Text] [Related]
9. [Radioimmunoscintigraphy with a 99mTc-labeled F(ab')2 fragment of a monoclonal antibody (HMW-MAA 225.28S) in 71 patients with malignant melanoma].
Rentsch M; Cerny T; Geiger L; Gerber H; Brunner KW; Rösler H; Nachbur B
Schweiz Med Wochenschr; 1989 Oct; 119(40):1382-5. PubMed ID: 2552577
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunoscintigraphy in patients with ocular melanoma.
Sergieva SB; Virtcheva-Genkova A
Clin Nucl Med; 1997 Jan; 22(1):25-9. PubMed ID: 8993869
[TBL] [Abstract][Full Text] [Related]
11. Quantitative comparison of direct antibody labeling and tumor pretargeting in uveal melanoma.
Magnani P; Paganelli G; Modorati G; Zito F; Songini C; Sudati F; Koch P; Maecke HR; Brancato R; Siccardi AG; Fazio F
J Nucl Med; 1996 Jun; 37(6):967-71. PubMed ID: 8683323
[TBL] [Abstract][Full Text] [Related]
12. The role of technetium-99m sestamibi single photon emission tomography in the follow-up of malignant melanoma and the detection of lymph node metastases.
Soler C; Perrot JL; Thiffet O; Beauchesne P; Lanthier K; Boucheron S; Dubois F; Cambazard F
Eur J Nucl Med; 1997 Dec; 24(12):1522-5. PubMed ID: 9391188
[TBL] [Abstract][Full Text] [Related]
13. Scintigraphic detection of invasive cutaneous malignant melanoma with Tc-99m MIBI.
Alonso O; Martinez M; Lago G; Bazzano C; Saadoun A; Mut F; Delgado L; Espasandin J; Touya E
Clin Nucl Med; 1996 Jul; 21(7):557-9. PubMed ID: 8818470
[TBL] [Abstract][Full Text] [Related]
14. Current role of immunoscintigraphy in malignant melanoma follow-up. A study of 114 patients.
Ribuffo D; Cavalieri L; De Vita F; Massa R; Prosperi D; Tuccimei M; Scuderi N
J Exp Clin Cancer Res; 2001 Mar; 20(1):11-5. PubMed ID: 11370816
[TBL] [Abstract][Full Text] [Related]
15. Primary malignant melanoma arising in an ovarian dermoid cyst: proposed use of radioimmunoscintigraphy with 99mTc-F(ab')2 antimelanoma antibody for staging and follow-up. Case report.
Di Vagno G; Mele M; Resta L; Maiorano E; Loverro G; Salzillo F; Masotina A; Selvaggi L; D'Addabbo A
Eur J Gynaecol Oncol; 1993; 14(3):237-45. PubMed ID: 8508882
[TBL] [Abstract][Full Text] [Related]
16. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
Moins N; D'Incan M; Bonafous J; Bacin F; Labarre P; Moreau MF; Mestas D; Noirault E; Chossat F; Berthommier E; Papon J; Bayle M; Souteyrand P; Madelmont JC; Veyre A
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1478-84. PubMed ID: 12397467
[TBL] [Abstract][Full Text] [Related]
17. [Immunoscintigraphy with a technetium 99m-labeled monoclonal antibody in patients with melanoma].
Dudczak R; Kletter K; Bailer H; Kokoschka E; Pohl-Markl H
Wien Klin Wochenschr; 1987 Apr; 99(7):232-9. PubMed ID: 3590802
[TBL] [Abstract][Full Text] [Related]
18. The role of cutaneous lymphoscintigraphy in determining regional lymph node drainage of truncal melanomas.
Fisher EB; Lewis VL; Griffith BH; Spies W
Ann Plast Surg; 1992 Jun; 28(6):506-10. PubMed ID: 1622030
[TBL] [Abstract][Full Text] [Related]
19. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
[TBL] [Abstract][Full Text] [Related]
20. Radioimaging of melanoma using 99mTc-labeled Fab fragment reactive with a high molecular weight melanoma antigen.
Lamki LM; Zukiwski AA; Shanken LJ; Legha SS; Benjamin RS; Plager CE; Salk DF; Schroff RW; Murray JL
Cancer Res; 1990 Feb; 50(3 Suppl):904s-908s. PubMed ID: 2297740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
